MENLO PARK, CA, Recode announced it has secured $15 million in funding, led by The Cystic Fibrosis Foundation.
Recode announced it has secured $15 million in funding, led by The Cystic Fibrosis Foundation. This investment is intended to be used to develop a gene editing therapy that could be delivered into the lung cells of people with cystic fibrosis.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
By VC News Daily
Source: VC News Daily